IS THE GLASS HALF FULL OR HALF EMPTY COMMENT Paul Thomas from pharmamanufacturing has submitted a list of what 13 "experts" believe to be occurring during 2012. Take a look at these to determine if you concur, disagree or have other thoughts to add. What Can Pharma Expect in 2012? The Glass is Half Full (and Half Empty) Submitted by pharmamanufacturing on Thu, … [Read more...]
CDER GUIDANCES 2011– NEW/REVISED/WITHDRAWN
During 2011 CDER released a number of new Guidance for Industry documents. Many of these documents are quite difficult to locate within knowing the exact name of the document. These documents include the very widely publicized Process Validation (January 2011), several relating to PET (Positron Emission Tomography) products and their approvals, as well … [Read more...]
BEN VENUE DETERMINES SIGNIFICANT REMEDIATION REQUIRED AT ITS BEDFORD, OHIO FACILITIES
"NORTH" FACILITY MAY NOT BE AVAILABLE FOR MFG OF STERILE INJECTABLES BEFORE 4th QUARTER 2012 COMMENT Ben Venue Laboratories issued an early "Christmas gift" press release on Friday, December 23 wherein they announced the decision to extend the voluntary suspension of manufacturing at its Bedford, OH facility. Ben Venue has determined that it can no longer both … [Read more...]
FDA INCREASES VIGILANCE ON ASEPTIC PROCESSING FACILITIES
 B/POR REVIEWS RISING TIDE OF FDA 483s AND WARNING LETTERS AT FIRMS TO INCLUDE BEN VENUE LABS, HOSPIRA AND FORMATECH COMMENT Policy changes and enforcement strategies implemented by the FDA have led to an increase in the number of inspection of sterile manufacturers -- especially injectables. There is greater … [Read more...]
JOINT AUDIT BY UK (MHRA) AND FRENCH (AFSSAPS) MEDICINES REGULATORY AGENCIES TOGETHER WITH FDA HIGHLIGHT ASEPTIC FILLING PROCESS DEFICIENCIES (11/7-11/11)
CHMP RECOMMENDS RECALL OF SELECTED BATCHES MFG AT BEN VENUE SUMMARY A joint GMP inspection of the Ben Venue site, where a number of sterile medicines are manufactured, by the UK and French medicines regulatory agencies together with the US FDA on 7-11 November 2011 highlighted several shortcomings in the quality management system, particularly in relation to the aseptic … [Read more...]
